ClinicalTrials.gg
RecruitingNCT06881784RASolve 301Updated Nov 6, 2026

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

A Phase 3 interventional study of daraxonrasib and docetaxel in NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer and NSCLC, sponsored by Revolution Medicines, Inc.. Recruiting at 199 sites in 19 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Revolution Medicines, Inc. · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.
Updated Nov 6, 2026Site recruiting status changed50 sites added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
590
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 13 studies in Carcinoma, Non-Small-Cell Lung by Revolution Medicines, Inc. — 8 open to participants now, 9 under way, 2 of them phase 3. Carcinoma, Non-Small-Cell Lung · Revolution Medicines, Inc..

Planned enrollment
4th of 13
590 · median 430
Started
2025
the only one that year
Phase 3
2 of 13
2 open now
Registered
10th of 13
by date

Among the 13 studies in Carcinoma, Non-Small-Cell Lung by Revolution Medicines, Inc., this one is the 4th largest by planned enrollment, is the only one that started in 2025, is one of 2 in phase 3, and was the 10th registered.

Carcinoma, Non-Small-Cell Lung

7,628 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,838 are open to participants now.

Browse Carcinoma, Non-Small-Cell Lung studies →

Open to participants now

8 of the 13 studies in Carcinoma, Non-Small-Cell Lung by Revolution Medicines, Inc. are open now, in 12 countries. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Who these studies take

Of the 1,325 Carcinoma, Non-Small-Cell Lung studies recruiting now, 988 (75%) set no upper age limit and 224 (17%) stop at 75 or younger; 34 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Carcinoma, Non-Small-Cell Lung by Revolution Medicines, Inc., or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.

Read the detailed description

This is a global, randomized, open-label, Phase 3 study designed to evaluate whether treatment with daraxonrasib will improve progression free survival (PFS) or overall survival (OS) compared to docetaxel chemotherapy in patients with NSCLC who were previously treated. Patients will be randomized in a 1:1 ratio to receive daraxonrasib or docetaxel chemotherapy.

03

Conditions studied

  • NSCLC (Non-small Cell Lung Cancer)
  • Non-Small Cell Lung Cancer
  • NSCLC
  • NSCLC (Non-small Cell Lung Carcinoma)
  • NSCLC (Advanced Non-small Cell Lung Cancer)

Keywords

  • NSCLC
  • Non-Small Cell Lung Cancer
  • Lung Cancer
  • RAS
  • KRAS
  • HRAS
  • NRAS
  • RAS Q61 Mutation
  • RAS G12 Mutation
  • RAS G13 Mutation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years old and has provided .
  • (ECOG) performance status of 0 or 1.
  • confirmed NSCLC, either locally advanced or , not amenable to curative surgery or radiotherapy.
  • per v1.1.
  • Adequate organ function (bone marrow, liver, kidney, coagulation).
  • One to two including an /anti-PD(L)-1 agent and platinum-based chemotherapy.
  • Documented RAS mutation status, defined as Nonsynonymous mutations in KRAS, NRAS, or HRAS at codons 12, 13, or 61 (G12, G13, or Q61).
  • Able to take oral medications.

Exclusion criteria

Exclusion Criteria:

  • Prior therapy with direct RAS-targeted therapy or docetaxel.
  • Untreated central nervous system (CNS) .
  • Medically significant comorbidities (significant cardiovascular disease, lung disease, or impaired GI function).
  • Ongoing anticancer therapy.
  • Pregnant or breastfeeding.
Terms in these criteria, in plain language(8)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ECOG performance status

A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.

0
Fully active, no restrictions.
1
Limited in strenuous activity, but walking and able to do light work, such as housework or office work.
2
Walking and able to look after yourself, but unable to work; up and about more than half of waking hours.
3
Able to look after yourself only in part; in bed or a chair more than half of waking hours.
4
Unable to look after yourself at all; in bed or a chair all day.

Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.

Histologically or cytologically confirmed

The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).

Your pathology report is the document that shows this.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

Measurable disease

The amount of disease can be tracked with a defined measurement, so the study can see whether it shrinks or grows. It might be a tumor measured on a scan or, in some blood cancers such as myeloma, a marker measured in blood or urine.

The criteria or the study team say which measurement counts — having no tumor visible on a scan does not by itself rule you out.

RECIST

The standard rules for measuring tumors on CT or MRI scans, to tell whether a cancer is shrinking, stable or growing during treatment.

“Measurable disease per RECIST 1.1” usually means at least one tumor 10 mm or more at its longest on a CT scan, or a lymph node 15 mm or more across its short axis.

Line of therapy

A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.

“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.

PD-1, PD-L1 and checkpoint inhibitors

PD-1, PD-L1 and CTLA-4 are proteins that act as brakes on the immune system. Checkpoint inhibitors, such as pembrolizumab or nivolumab, block them so the immune system can attack a cancer.

PD-L1 can also be measured in a tumor sample. Some scores count stained tumor cells only (TPS); others also count certain immune cells (CPS). The study names the score and the minimum it uses.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
590 participants (estimated)

Study arms

  • Experimental
    daraxonrasib

    study drug

    Drug: daraxonrasib

  • Active comparator
    docetaxel

    Patients randomized to the comparator control arm will receive docetaxel as the standard of care therapy.

    Drug: docetaxel

Interventions

06

What researchers measure

Primary outcomes

  1. Progression free survival (PFS) per Blinded Independent Central Review (BICR) in the RAS G12X-C population (i.e RAS G12X excluding G12C)

    PFS is defined as the time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per response evaluation criteria in solid tumors (RECIST) v1.1 and as assessed by BICR.

    Time frame: Up to approximately 4 years

  2. Overall survival (OS) in the RAS G12X-C population

    OS is defined as the time from randomization until death from any cause.

    Time frame: Up to approximately 4 years

Secondary outcomes

  1. PFS in the RAS (MUT) population per BICR

    PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by BICR.

    Time frame: Up to approximately 4 years

  2. OS in the RAS (MUT) population

    OS is defined as time from randomization until death from any cause.

    Time frame: up to approximately 4 years

  3. Objective response per BICR in the RAS (G12X-C) and RAS (MUT) populations

    Objective response of partial response (PR) or complete response (CR) per RECIST v1.1 as assessed by BICR.

    Time frame: Up to approximately 4 years

  4. PFS per Investigator in the RAS (G12X-C) and RAS (MUT) populations

    PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by Investigator.

    Time frame: Up to approximately 4 years

  5. Objective response per Investigator in the RAS (G12X-C) and RAS (MUT) populations

    Objective response of PR or CR per RECIST v1.1 as assessed by Investigator.

    Time frame: Up to approximately 4 years

  6. Duration of response (DOR) per Investigator and per BICR in the RAS (G12X-C) and RAS (MUT) populations

    DOR is defined as time from first evidence of objective response (PR or CR) to disease progression or death due to any cause, whichever occurs first, as assessed by Investigator and by BICR.

    Time frame: Up to approximately 4 years

  7. Time to response (TTR) per Investigator and per BICR in the RAS (G12X-C) and RAS (MUT) populations

    TTR is defined as time from randomization to first evidence of objective response (PR or CR), as assessed by Investigator and by BICR.

    Time frame: Up to approximately 4 years

  8. Treatment effect on quality of life (QoL) using EORTC QLQ-LC13 In the RAS (G12X-C) and RAS (MUT) populations

    Time to deterioration (TTD) in selected symptoms (dyspnea, chest pain, cough) defined as the time from randomization to the first onset of 10 points or more deterioration from baseline in the corresponding symptom scales (dyspnea, chest pain, cough) on European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire LC-13 (EORTC QLQ-LC13). Change from baseline on EORTC QLQ-LC13 in symptom scales (dyspnea, cough, chest pain).

    Time frame: Up to approximately 4 years

  9. Treatment effect on quality of life (QoL) using EORTC QLQ-C30 In the RAS (G12X-C) and RAS (MUT) populations

    Change from baseline in global quality of life score from European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire. Change from baseline on EORTC QLQ-C30 functioning domains (physical role, cognitive, emotional, social).

    Time frame: Up to approximately 4 years

  10. Safety and tolerability in the RAS (G12X-C) and RAS (MUT) population

    Incidence of treatment emergent adverse events (TEAEs), treatment related adverse events (TRAEs), serious adverse events (SAEs), changes in vital signs and clinical laboratory tests.

    Time frame: Up to approximately 4 years

  11. PK characterization of daraxonrasib In the RAS (MUT) population

    Predose and post-dose blood concentrations of daraxonrasib over time.

    Time frame: Up to approximately 4 years

07

Study locations

26 of 199 sites recruiting
  • Alabama Oncology
    Birmingham, Alabama 35243, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Loma Linda University
    Loma Linda, California 92408, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • MemorialCare Long Beach Medical Center
    Long Beach, California 90806, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • UC Irvine Health
    Orange, California 92868, United States
    Recruiting
  • UCHealth Memorial Hospital Central
    Colorado Springs, Colorado 80909, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Yale University, Smillow Cancer Center
    New Haven, Connecticut 06519, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Florida Cancer Specialists & Research Institute - South
    Fort Myers, Florida 33901, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • BRCR Global
    Plantation, Florida 33322, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Florida Cancer Specialists & Research Institute - North
    St. Petersburg, Florida 33705, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cleveland Clinic Martin North
    Stuart, Florida 34994, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Florida Cancer Specialists & Research Institute - East
    West Palm Beach, Florida 33401, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University Cancer and Blood Center
    Athens, Georgia 30607, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Piedmont Healthcare, Inc
    Atlanta, Georgia 30318, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Winship Cancer Institute
    Atlanta, Georgia 30322, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Rush University Medical Center
    Chicago, Illinois 60607, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Illinois Cancer Center
    Chicago, Illinois 60612, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Chicago Medical Center
    Chicago, Illinois 60637, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Community Health Network
    Indianapolis, Indiana 46250, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Iowa Health Care Cancer Services Quad Cities
    Bettendorf, Iowa 52722, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Iowa Hospitals & Clinics
    Iowa City, Iowa 52242, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Iowa Health Care, Mission Cancer + Blood
    Waukee, Iowa 50263, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • The University of Kansas Cancer Center
    Westwood, Kansas 66205, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Maryland Greenebaum Comprehensive Cancer Center.
    Baltimore, Maryland 21201, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Johns Hopkins University of Medicine
    Baltimore, Maryland 21224, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Trinity Health Ann Arbor Hospital
    Ann Arbor, Michigan 48106, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Karmanos Cancer Institute
    Detroit, Michigan 48201, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Brigitte Harris Cancer Pavilion BHCP
    Detroit, Michigan 48202, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Washington University School of Medicine - Siteman Cancer Center
    St Louis, Missouri 63110, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • St. Vincent Frontier Cancer Center
    Billings, Montana 59102, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Comprehensive Cancer Centers of Nevada
    Henderson, Nevada 89014, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • John Theurer Cancer Center at Hackensack UMC
    Hackensack, New Jersey 07601, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Morristown Medical Center (MMCORC)
    Morristown, New Jersey 07960, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Roswell Park Cancer Institute
    Buffalo, New York 14263, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Memorial Sloan Kettering Cancer Center
    New York, New York 10065, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Montefiore Medical Center
    The Bronx, New York 10461, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • UNC Lineberger Comprehensive Cancer Center at University of North Carolina
    Chapel Hill, North Carolina 27599, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • TriHealth Cancer & Blood Institute Research
    Cincinnati, Ohio 45220, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Taylor Cancer Research Center
    Maumee, Ohio 43537, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Oncology Associates of Oregon PC
    Eugene, Oregon 97401, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Avera Saint Luke's Hospital
    Aberdeen, South Dakota 57401, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Avera Cancer Institute
    Sioux Falls, South Dakota 57105, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • SCRI Oncology Partners - Tennessee
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Texas Oncology - South Austin
    Austin, Texas 78745, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Texas Oncology Dallas
    Dallas, Texas 75251, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • MD Anderson Cancer Center
    Houston, Texas 77030, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cancer Care Centers of Brevard
    Irving, Texas 75063, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • US Oncology Investigational Products Center (IPC)
    Irving, Texas 75063, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Texas Oncology - Gulf Coast
    The Woodlands, Texas 77380, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Utah Cancer Specialists
    Salt Lake City, Utah 84106, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Huntsman Cancer Institute
    Salt Lake City, Utah 84112, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Virginia Cancer Specialists
    Fairfax, Virginia 22031, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Blacktown Medical Oncology Research, Blacktown Hospital
    Blacktown, New South Wales 2148, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Chris O'Brien Lifehouse
    Camperdown, New South Wales 2050, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • St. George Private Hospital Clinical Trials Unit
    Kogarah, New South Wales 2217, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Calvary Mater Newcastle
    Waratah, New South Wales 2298, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mater Misericordiae Limited
    South Brisbane, Queensland 4101, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Alfred House
    Melbourne, Victoria 3004, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Sir Charles Gairdner Hospital
    Perth, Western Australia 6009, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut Jules Bordet
    Anderlecht, Belgium 1070, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • UZA
    Edegem, 2650, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Grand Hôpital de Charleroi - Les Viviers
    Gilly, 6060, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • AZ Groeninge
    Kortrijk, 8500, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • UZ Leuven-Campus Gasthuisberg
    Leuven, 3000, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • AZ Delta
    Roeselare, 8800, Belgium
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU Strasbourg - Nouvel Hôpital Civil
    Strasbourg, Bas Rhin 67091, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hopital Nord - CHU Marseille
    Marseille, Bouches-du-Rhône 13915, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut régional du Cancer de Montpellier
    Montpellier, Herault 34298, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU Rennes Hôpital Pontchaillou
    Rennes, Ille et Vilaine 35033, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU de Grenoble - Hôpital Albert Michallon
    La Tronche, Isere 38700, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU Nantes - Hôpital Guillaume et René Laënnec
    Saint-Herblain, Loire Atlantique 44805, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut de Cancerologie de l Ouest
    Saint-Herblain, Loire Atlantique 44805, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Centre Leon Berard
    Léon, Lyon 69008, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hopital Albert Calmette - CHU Lille
    Lille, Nord 59037, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut Curie-site de Paris
    Paris, Paris 75005, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hôpital Bichat - Claude Bernard
    Paris, Paris 75018, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hopital Louis Pradel
    Bron, Rhone 69677, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Centre Hospitalier Intercommunal de Créteil
    Créteil, Val de Marne 94000, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut Gustave Roussy
    Vaillant, Villejuif 94800, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU Brest - Hôpital Morvan
    Brest, 29200, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Institut Bergonie
    Gironde, 33076, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CHU de Toulouse - Hopital Larrey
    Toulouse, 31059, France
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Asklepios Fachkliniken Muenchen-Gauting
    Gauting, Bavaria 82131, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Muenchen Klinik Bogenhausen
    München, Bavaria 81925, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen
    Giesen, Hesse 35392, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • LKI Lungenfachklinik Immenhausen
    Immenhausen, Hesse 34376, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitaetsmedizin Goettingen
    Göttingen, Lower Saxony 37075, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitaetsklinikum Essen
    Essen, North Rhine-Westphalia 45147, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitaetsklinikum Carl Gustav Carus TU Dresden
    Dresden, Saxony 01307, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitaetsklinikum Schleswig-Holstein - Campus Luebeck
    Lübeck, Schleswig-Holstein 23538, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Thoraxklinik Heidelberg gGmbH
    Baden, Wuerttemberg 69469, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Klinikum Esslingen GmbH
    Baden, 73730, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Evangelische Lungenklinik Berlin
    Berlin, 13125, Germany
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hong Kong United Oncology Centre
    Hong Kong, Hong Kong
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Queen Mary Hospital
    Hong Kong, Hong Kong
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Princess Margaret Hospital
    Lai Chi Kok, Hong Kong
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • The Chinese University of Hong Kong
    Shatin, 00000, Hong Kong
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cork Univeristy Hospital
    Cork, Cork T12 DC4A, Ireland
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mater Private Hospital
    Dublin, Dublin 7, Ireland
    Active, not recruiting

    Not enrolling at this site — choose another above.

Showing the first 100 of 199 sites across 19 countries. Choose a country and city above to see the rest.

08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Dec 2027, 30 months after the start.

Of 315 industry-sponsored phase 3 interventional studies under Carcinoma, Non-Small-Cell Lung, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 57. This study's planned 30 months is below that.

Counting every sponsor, half of 424 studies reached it within 45 months; a quarter within 30 and three quarters within 69.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2025
First posted
Mar 18, 2025
StartActual
May 6, 2025
Primary completionEst.
Dec 1, 2027
CompletionEst.
Dec 1, 2030
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
50 sites added, 4 sites removed. 131 sites changed recruiting status (131 now active, not recruiting)
Show 131 sites
  • Alabama Oncology · Birmingham, United StatesRecruiting→Active, not recruiting
  • MemorialCare Long Beach Medical Center · Long Beach, United StatesRecruiting→Active, not recruiting
  • Yale University, Smillow Cancer Center · New Haven, United StatesRecruiting→Active, not recruiting
  • Florida Cancer Specialists & Research Institute - South · Fort Myers, United StatesRecruiting→Active, not recruiting
  • BRCR Global · Plantation, United StatesRecruiting→Active, not recruiting
  • Florida Cancer Specialists & Research Institute - North · St. Petersburg, United StatesRecruiting→Active, not recruiting
  • Cleveland Clinic Martin North · Stuart, United StatesRecruiting→Active, not recruiting
  • Florida Cancer Specialists & Research Institute - East · West Palm Beach, United StatesRecruiting→Active, not recruiting
  • University Cancer and Blood Center · Athens, United StatesRecruiting→Active, not recruiting
  • Piedmont Healthcare, Inc · Atlanta, United StatesRecruiting→Active, not recruiting
  • Winship Cancer Institute · Atlanta, United StatesRecruiting→Active, not recruiting
  • University of Illinois Cancer Center · Chicago, United StatesRecruiting→Active, not recruiting
  • University of Iowa Health Care Cancer Services Quad Cities · Bettendorf, United StatesRecruiting→Active, not recruiting
  • University of Iowa Hospitals & Clinics · Iowa City, United StatesRecruiting→Active, not recruiting
  • University of Iowa Health Care, Mission Cancer + Blood · Waukee, United StatesRecruiting→Active, not recruiting
  • The University of Kansas Cancer Center · Westwood, United StatesRecruiting→Active, not recruiting
  • Johns Hopkins University of Medicine · Baltimore, United StatesRecruiting→Active, not recruiting
  • Trinity Health Ann Arbor Hospital · Ann Arbor, United StatesRecruiting→Active, not recruiting
  • Karmanos Cancer Institute · Detroit, United StatesRecruiting→Active, not recruiting
  • Washington University School of Medicine - Siteman Cancer Center · St Louis, United StatesRecruiting→Active, not recruiting
  • St. Vincent Frontier Cancer Center · Billings, United StatesRecruiting→Active, not recruiting
  • Dartmouth-Hitchcock Medical Center · Lebanon, United StatesRecruiting→Active, not recruiting
  • John Theurer Cancer Center at Hackensack UMC · Hackensack, United StatesRecruiting→Active, not recruiting
  • Morristown Medical Center (MMCORC) · Morristown, United StatesRecruiting→Active, not recruiting
  • Roswell Park Cancer Institute · Buffalo, United StatesRecruiting→Active, not recruiting
  • Memorial Sloan Kettering Cancer Center · New York, United StatesRecruiting→Active, not recruiting
  • Montefiore Medical Center · The Bronx, United StatesRecruiting→Active, not recruiting
  • UNC Lineberger Comprehensive Cancer Center at University of North Carolina · Chapel Hill, United StatesRecruiting→Active, not recruiting
  • TriHealth Cancer & Blood Institute Research · Cincinnati, United StatesRecruiting→Active, not recruiting
  • Taylor Cancer Research Center · Maumee, United StatesRecruiting→Active, not recruiting
  • …and 101 more on the registry record
Show 50 added (13 United States, 13 Spain, 8 Italy, 5 Germany, 4 United Kingdom, 3 Japan, 1 Belgium, 1 France, 1 Netherlands, 1 Switzerland)
  • University of Illinois Cancer Center · Chicago, United States
  • Trinity Health Ann Arbor Hospital · Ann Arbor, United States
  • Kitasato University Hospital · Sagamihara, Japan
  • University Hospital, Kyoto Prefectural University of Medicine · Kyoto, Japan
  • Saitama Medical University International Medical Center · Hidaka, Japan
  • Loma Linda University · Loma Linda, United States
  • UC Irvine Health · Orange, United States
  • UCHealth Memorial Hospital Central · Colorado Springs, United States
  • Rush University Medical Center · Chicago, United States
  • University of Chicago Medical Center · Chicago, United States
  • Community Health Network · Indianapolis, United States
  • University of Maryland Greenebaum Comprehensive Cancer Center. · Baltimore, United States
  • Brigitte Harris Cancer Pavilion BHCP · Detroit, United States
  • Comprehensive Cancer Centers of Nevada · Henderson, United States
  • Cancer Care Centers of Brevard · Irving, United States
  • US Oncology Investigational Products Center (IPC) · Irving, United States
  • UZA · Edegem, Belgium
  • Institut Curie-site de Paris · Paris, France
  • Asklepios Fachkliniken Muenchen-Gauting · Gauting, Germany
  • Muenchen Klinik Bogenhausen · München, Germany
  • Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen · Giesen, Germany
  • Universitaetsmedizin Goettingen · Göttingen, Germany
  • Universitaetsklinikum Schleswig-Holstein - Campus Luebeck · Lübeck, Germany
  • Ospedale San Raffaele · Milan, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori · Milan, Italy
  • Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli" · Naples, Italy
  • Azienda Ospedaliero Universitaria di Parma · Parma, Italy
  • Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia · Perugia, Italy
  • Fondazione Policlinico Universitario Campus Bio-Medico* · Roma, Italy
  • Azienda Ospedaliero-Universitaria S.Luigi Gonzaga · Orbassano, Italy
  • …and 20 more on the registry record
Show 4 removed
  • Cancer Care Centers of Breevard · Rockledge, United States
  • Center for Care and Discovery · Chicago, United States
  • Henry Ford Health · Detroit, United States
  • Blacktown Medical Oncology Research · Blacktown, Australia
across 2 updates, Sep 29, 2026 – Nov 6, 2026
Site contacts
Changed at 131 sites. See the sites
Show 131 sites
  • Alabama Oncology · Birmingham, United StatesContact removed S•••@alabamaoncology.com · •••4369
  • MemorialCare Long Beach Medical Center · Long Beach, United StatesContact removed L•••@memorialcare.org · •••2701
  • Yale University, Smillow Cancer Center · New Haven, United StatesContact removed j•••@yale.edu · •••3732
  • Florida Cancer Specialists & Research Institute - South · Fort Myers, United StatesContact removed R•••@flcancer.com · •••1143
  • BRCR Global · Plantation, United StatesContact removed f•••@brcrglobal.com · •••0614
  • Florida Cancer Specialists & Research Institute - North · St. Petersburg, United StatesContact removed R•••@flcancer.com · •••9930
  • Cleveland Clinic Martin North · Stuart, United StatesContact removed G•••@ccf.org · •••2146
  • Florida Cancer Specialists & Research Institute - East · West Palm Beach, United StatesContact removed R•••@flcancer.com · •••4100
  • University Cancer and Blood Center · Athens, United StatesContact removed r•••@universitycancer.com · •••5006
  • Piedmont Healthcare, Inc · Atlanta, United StatesContact removed k•••@piedmont.org · •••7938
  • Winship Cancer Institute · Atlanta, United StatesContact removed r•••@emory.edu · •••1900
  • University of Illinois Cancer Center · Chicago, United StatesContact removed m•••@uic.edu · •••5112
  • University of Iowa Health Care Cancer Services Quad Cities · Bettendorf, United StatesContact removed w•••@uiowa.edu · •••1770
  • University of Iowa Hospitals & Clinics · Iowa City, United StatesContact removed w•••@uiowa.edu · •••1770
  • University of Iowa Health Care, Mission Cancer + Blood · Waukee, United StatesContact removed w•••@uiowa.edu · •••1770
  • The University of Kansas Cancer Center · Westwood, United StatesContact removed C•••@kumc.edu · •••7552
  • Johns Hopkins University of Medicine · Baltimore, United StatesContact removed T•••@jhmi.edu
  • Trinity Health Ann Arbor Hospital · Ann Arbor, United StatesContact removed M•••@trinity-health.org · •••7251
  • Karmanos Cancer Institute · Detroit, United StatesContact removed g•••@karmanos.org · •••6266
  • Washington University School of Medicine - Siteman Cancer Center · St Louis, United StatesContact removed M•••@dom.wustl.edu · •••1171
  • St. Vincent Frontier Cancer Center · Billings, United StatesContact removed H•••@imail.org · •••6996
  • Dartmouth-Hitchcock Medical Center · Lebanon, United StatesContact removed c•••@hitchcock.org
  • John Theurer Cancer Center at Hackensack UMC · Hackensack, United StatesContact removed O•••@hmhn.org · •••1777
  • Morristown Medical Center (MMCORC) · Morristown, United StatesContact removed m•••@atlantichealth.org
  • Roswell Park Cancer Institute · Buffalo, United StatesContact removed E•••@roswellpark.org · •••3099
  • Memorial Sloan Kettering Cancer Center · New York, United StatesContact removed a•••@mskcc.org · •••3792
  • Montefiore Medical Center · The Bronx, United StatesContact removed Y•••@montefiore.org · •••8516Contact removed c•••@einsteinmed.edu · •••8535
  • UNC Lineberger Comprehensive Cancer Center at University of North Carolina · Chapel Hill, United StatesContact removed g•••@email.unc.edu · •••0000
  • TriHealth Cancer & Blood Institute Research · Cincinnati, United StatesContact removed P•••@trihealth.com · •••5249
  • Taylor Cancer Research Center · Maumee, United StatesContact removed s•••@tcrcpt.org · •••4500
  • …and 101 more sites
Nov 6, 2026
Show all 2 updates
  1. Nov 6, 2026
    45 sites added, 4 sites removed. 131 sites changed recruiting status (131 now active, not recruiting)
    Show 131 sites
    • Alabama Oncology · Birmingham, United StatesRecruiting→Active, not recruiting
    • MemorialCare Long Beach Medical Center · Long Beach, United StatesRecruiting→Active, not recruiting
    • Yale University, Smillow Cancer Center · New Haven, United StatesRecruiting→Active, not recruiting
    • Florida Cancer Specialists & Research Institute - South · Fort Myers, United StatesRecruiting→Active, not recruiting
    • BRCR Global · Plantation, United StatesRecruiting→Active, not recruiting
    • Florida Cancer Specialists & Research Institute - North · St. Petersburg, United StatesRecruiting→Active, not recruiting
    • Cleveland Clinic Martin North · Stuart, United StatesRecruiting→Active, not recruiting
    • Florida Cancer Specialists & Research Institute - East · West Palm Beach, United StatesRecruiting→Active, not recruiting
    • University Cancer and Blood Center · Athens, United StatesRecruiting→Active, not recruiting
    • Piedmont Healthcare, Inc · Atlanta, United StatesRecruiting→Active, not recruiting
    • Winship Cancer Institute · Atlanta, United StatesRecruiting→Active, not recruiting
    • University of Illinois Cancer Center · Chicago, United StatesRecruiting→Active, not recruiting
    • University of Iowa Health Care Cancer Services Quad Cities · Bettendorf, United StatesRecruiting→Active, not recruiting
    • University of Iowa Hospitals & Clinics · Iowa City, United StatesRecruiting→Active, not recruiting
    • University of Iowa Health Care, Mission Cancer + Blood · Waukee, United StatesRecruiting→Active, not recruiting
    • The University of Kansas Cancer Center · Westwood, United StatesRecruiting→Active, not recruiting
    • Johns Hopkins University of Medicine · Baltimore, United StatesRecruiting→Active, not recruiting
    • Trinity Health Ann Arbor Hospital · Ann Arbor, United StatesRecruiting→Active, not recruiting
    • Karmanos Cancer Institute · Detroit, United StatesRecruiting→Active, not recruiting
    • Washington University School of Medicine - Siteman Cancer Center · St Louis, United StatesRecruiting→Active, not recruiting
    • St. Vincent Frontier Cancer Center · Billings, United StatesRecruiting→Active, not recruiting
    • Dartmouth-Hitchcock Medical Center · Lebanon, United StatesRecruiting→Active, not recruiting
    • John Theurer Cancer Center at Hackensack UMC · Hackensack, United StatesRecruiting→Active, not recruiting
    • Morristown Medical Center (MMCORC) · Morristown, United StatesRecruiting→Active, not recruiting
    • Roswell Park Cancer Institute · Buffalo, United StatesRecruiting→Active, not recruiting
    • Memorial Sloan Kettering Cancer Center · New York, United StatesRecruiting→Active, not recruiting
    • Montefiore Medical Center · The Bronx, United StatesRecruiting→Active, not recruiting
    • UNC Lineberger Comprehensive Cancer Center at University of North Carolina · Chapel Hill, United StatesRecruiting→Active, not recruiting
    • TriHealth Cancer & Blood Institute Research · Cincinnati, United StatesRecruiting→Active, not recruiting
    • Taylor Cancer Research Center · Maumee, United StatesRecruiting→Active, not recruiting
    • …and 101 more on the registry record
    Show 45 added (13 Spain, 11 United States, 8 Italy, 5 Germany, 4 United Kingdom, 1 Belgium, 1 France, 1 Netherlands, 1 Switzerland)
    • Loma Linda University · Loma Linda, United States
    • UC Irvine Health · Orange, United States
    • UCHealth Memorial Hospital Central · Colorado Springs, United States
    • Rush University Medical Center · Chicago, United States
    • University of Chicago Medical Center · Chicago, United States
    • Community Health Network · Indianapolis, United States
    • University of Maryland Greenebaum Comprehensive Cancer Center. · Baltimore, United States
    • Brigitte Harris Cancer Pavilion BHCP · Detroit, United States
    • Comprehensive Cancer Centers of Nevada · Henderson, United States
    • Cancer Care Centers of Brevard · Irving, United States
    • US Oncology Investigational Products Center (IPC) · Irving, United States
    • UZA · Edegem, Belgium
    • Institut Curie-site de Paris · Paris, France
    • Asklepios Fachkliniken Muenchen-Gauting · Gauting, Germany
    • Muenchen Klinik Bogenhausen · München, Germany
    • Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen · Giesen, Germany
    • Universitaetsmedizin Goettingen · Göttingen, Germany
    • Universitaetsklinikum Schleswig-Holstein - Campus Luebeck · Lübeck, Germany
    • Ospedale San Raffaele · Milan, Italy
    • Fondazione IRCCS Istituto Nazionale dei Tumori · Milan, Italy
    • Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli" · Naples, Italy
    • Azienda Ospedaliero Universitaria di Parma · Parma, Italy
    • Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia · Perugia, Italy
    • Fondazione Policlinico Universitario Campus Bio-Medico* · Roma, Italy
    • Azienda Ospedaliero-Universitaria S.Luigi Gonzaga · Orbassano, Italy
    • Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Trento) · Verona, Italy
    • Universitair Medisch Centrum Groningen · Groningen, Netherlands
    • Hospital Universitari Vall d'Hebron - VHIO · Barcelona, Spain
    • Hospital Clinic de Barcelona · Barcelona, Spain
    • ICO l'Hospitalet - Hospital Duran i Reynals · Barcelona, Spain
    • …and 15 more on the registry record
    Show 4 removed
    • Cancer Care Centers of Breevard · Rockledge, United States
    • Center for Care and Discovery · Chicago, United States
    • Henry Ford Health · Detroit, United States
    • Blacktown Medical Oncology Research · Blacktown, Australia
    Site contacts Changed at 131 sites. See the sites
    Show 131 sites
    • Alabama Oncology · Birmingham, United StatesContact removed S•••@alabamaoncology.com · •••4369
    • MemorialCare Long Beach Medical Center · Long Beach, United StatesContact removed L•••@memorialcare.org · •••2701
    • Yale University, Smillow Cancer Center · New Haven, United StatesContact removed j•••@yale.edu · •••3732
    • Florida Cancer Specialists & Research Institute - South · Fort Myers, United StatesContact removed R•••@flcancer.com · •••1143
    • BRCR Global · Plantation, United StatesContact removed f•••@brcrglobal.com · •••0614
    • Florida Cancer Specialists & Research Institute - North · St. Petersburg, United StatesContact removed R•••@flcancer.com · •••9930
    • Cleveland Clinic Martin North · Stuart, United StatesContact removed G•••@ccf.org · •••2146
    • Florida Cancer Specialists & Research Institute - East · West Palm Beach, United StatesContact removed R•••@flcancer.com · •••4100
    • University Cancer and Blood Center · Athens, United StatesContact removed r•••@universitycancer.com · •••5006
    • Piedmont Healthcare, Inc · Atlanta, United StatesContact removed k•••@piedmont.org · •••7938
    • Winship Cancer Institute · Atlanta, United StatesContact removed r•••@emory.edu · •••1900
    • University of Illinois Cancer Center · Chicago, United StatesContact removed m•••@uic.edu · •••5112
    • University of Iowa Health Care Cancer Services Quad Cities · Bettendorf, United StatesContact removed w•••@uiowa.edu · •••1770
    • University of Iowa Hospitals & Clinics · Iowa City, United StatesContact removed w•••@uiowa.edu · •••1770
    • University of Iowa Health Care, Mission Cancer + Blood · Waukee, United StatesContact removed w•••@uiowa.edu · •••1770
    • The University of Kansas Cancer Center · Westwood, United StatesContact removed C•••@kumc.edu · •••7552
    • Johns Hopkins University of Medicine · Baltimore, United StatesContact removed T•••@jhmi.edu
    • Trinity Health Ann Arbor Hospital · Ann Arbor, United StatesContact removed M•••@trinity-health.org · •••7251
    • Karmanos Cancer Institute · Detroit, United StatesContact removed g•••@karmanos.org · •••6266
    • Washington University School of Medicine - Siteman Cancer Center · St Louis, United StatesContact removed M•••@dom.wustl.edu · •••1171
    • St. Vincent Frontier Cancer Center · Billings, United StatesContact removed H•••@imail.org · •••6996
    • Dartmouth-Hitchcock Medical Center · Lebanon, United StatesContact removed c•••@hitchcock.org
    • John Theurer Cancer Center at Hackensack UMC · Hackensack, United StatesContact removed O•••@hmhn.org · •••1777
    • Morristown Medical Center (MMCORC) · Morristown, United StatesContact removed m•••@atlantichealth.org
    • Roswell Park Cancer Institute · Buffalo, United StatesContact removed E•••@roswellpark.org · •••3099
    • Memorial Sloan Kettering Cancer Center · New York, United StatesContact removed a•••@mskcc.org · •••3792
    • Montefiore Medical Center · The Bronx, United StatesContact removed Y•••@montefiore.org · •••8516Contact removed c•••@einsteinmed.edu · •••8535
    • UNC Lineberger Comprehensive Cancer Center at University of North Carolina · Chapel Hill, United StatesContact removed g•••@email.unc.edu · •••0000
    • TriHealth Cancer & Blood Institute Research · Cincinnati, United StatesContact removed P•••@trihealth.com · •••5249
    • Taylor Cancer Research Center · Maumee, United StatesContact removed s•••@tcrcpt.org · •••4500
    • …and 101 more sites
  2. Sep 29, 2026
    5 sites added
    Show 5 added (3 Japan, 2 United States)
    • University of Illinois Cancer Center · Chicago, United States
    • Trinity Health Ann Arbor Hospital · Ann Arbor, United States
    • Kitasato University Hospital · Sagamihara, Japan
    • University Hospital, Kyoto Prefectural University of Medicine · Kyoto, Japan
    • Saitama Medical University International Medical Center · Hidaka, Japan

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06881784
Responsible party
Sponsor
First posted
Mar 18, 2025
Start date
May 6, 2025
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2030 (estimated)
Last update
Nov 6, 2026

Study contacts

Revolution Medicines Study Director
Contact
medinfo@revmed.com
1-844-2-REVMED

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Daraxonrasib

Start the discussion